Watch our presentation from BPI Digital Week, hosted by Renee Tobias, to hear how our customers are using the Opto™ CLD workflow to find the best cell lines with the most confident monoclonality in just day and de-risk their path to IND faster.
Learn how the Beacon system’s superior cloning technology, automated imaging capabilities, and in-process quality controls provide definitive evidence of monoclonality to support regulatory approvals.
Find out how the Opto™ CLD workflow lets you generate the best production cell lines for complex antibody therapeutics with >99% monoclonality assurance in just days.
Find out how Catalent Biologics is able to select significantly higher expressing clonal cell lines with the Opto CLD workflow.